Drug Trial Radar · NCT03845582
Phase 2/3 Study of ALK-001 in Geographic Atrophy
Last checked: Nov 19, 2026Latest source record: Nov 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
May 7, 2019
Primary completion
Jul 25, 2023
Study completion Jun 30, 2024
Sponsor
- Lead sponsor
- Alkeus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 19, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-masked, multicenter, randomized, placebo-controlled clinical trial, evaluating the efficacy and safety of ALK-001 in participants with Geographic Atrophy (GA) secondary to age-related macular degeneration (AMD). Up to 200 participants will receive ALK-001 while up to 100 participants will receive a placebo.
Conditions
- Geographic Atrophy
- Age Related Macular Degeneration
- AMD
- Atrophy, Geographic
Interventions
ALK-001 oral capsuleDrug
Daily administration for 24 months
Placebo oral capsuleDrug
Daily administration for 24 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Growth Rate of GA Lesions, as Assessed by Fundus Autofluorescence (FAF)Time frame: Baseline to 24 months
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Alkeus Site
Phoenix, Arizona
Alkeus Site
Beverly Hills, California
Alkeus Site
Lakewood, Colorado
Alkeus Site
Clearwater, Florida
Alkeus Site
Fort Myers, Florida
Alkeus Site
Gainesville, Florida
Alkeus Site
Tampa, Florida
Alkeus Site
Winter Haven, Florida
Alkeus Site
Bloomington, Illinois
Alkeus Site
Lexington, Kentucky
Alkeus Site
Chevy Chase, Maryland
Alkeus Site
Worcester, Massachusetts
Alkeus Site
Grand Rapids, Michigan
Alkeus Site
Edina, Minnesota
Alkeus Site
Northfield, New Jersey
Alkeus Site
Great Neck, New York
Alkeus Site
Hauppauge, New York
Alkeus Site
Cleveland, Ohio
Alkeus Site
Ashland, Oregon
Alkeus Site
Houston, Texas
Alkeus Site-1
San Antonio, Texas
Alkeus Site-2
San Antonio, Texas
Alkeus Site
Fairfax, Virginia
Alkeus Site
Silverdale, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.